Figure 1
From: Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
![Figure 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fbcr767/MediaObjects/13058_2003_Article_769_Fig1_HTML.jpg)
(a) The 5-year disease-free survival (DFS) was 85.7% (95% confidence interval [CI] 84.4–87.1%) for invasive lobular carcinoma (ILC) versus 83.5% (95% CI 83.1–84.0%) for invasive ductal carcinoma (IDC; P = 0.13). (b) The 5-year overall survival (OS) was 85.6% (95% CI 84.2–87.0%) for ILC and 84.1% (95% CI 83.7–84.6%) for IDC (P = 0.64).